Logo image of MNMD

MIND MEDICINE MINDMED INC (MNMD) Stock Analyst Earnings Estimates

NASDAQ:MNMD - Nasdaq - CA60255C8850 - Common Stock - Currency: USD

7.63  -0.55 (-6.72%)

After market: 7.6979 +0.07 (+0.89%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MNMD revenue by date.MNMD revenue by date.
N/AN/AN/AN/AN/A
686.12%		N/A
206.29%		N/A
135.49%		N/A
37.58%		N/A
26.89%		N/A
-18.54%
EBITDA
YoY % growth
MNMD ebitda by date.MNMD ebitda by date.
N/AN/A-150K-1.22M
-713.33%		-850K
30.33%		-460K
45.88%		-33.03M
-7,080.43%		-91.23M
-176.20%		-63.15M
30.78%		-90.704M
-43.63%		N/A
-7.67%		N/A
-12.48%		N/A
-9.38%		N/A
-1.57%		N/A
95.11%		N/A
3,608.63%		N/A
19.46%		N/A
96.29%		N/A
54.04%
EBIT
YoY % growth
MNMD ebit by date.MNMD ebit by date.
-70K-50K
28.57%		-150K
-200.00%		-1.23M
-720.00%		-860K
30.08%		-470K
45.35%		-33.03M
-6,927.66%		-93.85M
-184.14%		-66.33M
29.32%		-93.866M
-41.51%		N/A
-7.38%		N/A
-28.49%		N/A
-9.21%		N/A
53.63%		N/A
253.68%		N/A
328.60%		N/A
66.10%		N/A
34.24%		N/A
-41.87%
Operating Margin
MNMD operating margin by date.MNMD operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MNMD eps by date.MNMD eps by date.
N/AN/AN/AN/AN/AN/AN/AN/A
-106.06%		-1.92
44.64%		-2.32
-20.83%		N/A
34.30%		N/A
0.79%		N/A
-1.73%		N/A
50.60%		N/A
155.03%		N/A
471.34%		N/A
77.27%		N/A
30.28%		N/A
-13.86%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.30
48.86%		-0.35
69.09%		-0.37
-40.56%		-0.39
-44.90%		-0.36
-19.45%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-25.347M
-33.10%		-26.571M
-22.58%		-26.724M
-11.67%		-28.203M
-16.23%		-30.09M
-18.71%
EBIT
Q2Q % growth		-27.8M
-25.20%		-29.326M
-32.08%		-30.547M
-24.89%		-32.783M
-32.23%		-34.523M
-24.18%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.27
40.00%		-0.290.025.46%
Q2 2024
Q2Q % growth		 -0.26
65.79%		-0.340.0822.50%
Q1 2024
Q2Q % growth		 -1.14
-119.23%		-0.54-0.60-111.45%
Q4 2023
Q2Q % growth		 -0.59
-268.75%		-0.47-0.12-24.97%
Q3 2023
Q2Q % growth		 -0.45
19.64%		-0.690.2434.64%
Q2 2023
Q2Q % growth		 -0.76
-26.67%		-0.55-0.21-38.84%
Q1 2023
Q2Q % growth		 -0.52
13.33%		-0.43-0.09-20.24%
Q4 2022
Q2Q % growth		 -0.16
-220.00%		-0.510.3568.84%
Q3 2022
Q2Q % growth		 -0.56 -0.610.057.88%
Q2 2022
Q2Q % growth		 -0.60 -0.770.1721.57%
Q1 2022
Q2Q % growth		 -0.60 -0.770.1721.57%
Q4 2021
Q2Q % growth		 -0.05
66.67%		-0.970.9294.83%
Q4 2020
Q2Q % growth		 -0.15 -0.310.1650.98%
Q3 2020
Q2Q % growth		 -0.45 -0.460.011.96%
MNMD Yearly EPS VS EstimatesMNMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 -2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
MNMD Yearly Revenue VS EstimatesMNMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS6.56% 3.54% -0.4% 3.9%
RevenueN/A N/A N/A N/A